World-Renowned Medical Experts to Discuss Changing Treatment Paradigms to Reduce Mortality in Patients with Diabetes, Cardiovascular and Kidney Disease
The 4th Annual Heart in Diabetes now FREE LIVE INTERACTIVE ONLINE
August 12, 2020, NEW YORK — Recent cardiovascular outcomes trials demonstrating reduced cardiovascular events and mortality have led to revised treatment guidelines for patients with diabetes, kidney, liver, and cardiovascular disorders. In the era of COVID-19, implementing these guidelines in clinical practice is even more challenging yet essential to maintaining the health of patients with these disorders. World-renowned experts in diabetes, cardiology, nephrology, cholesterol, and other cardiometabolic conditions will assemble for the 4th Annual Heart in Diabetes conference to discuss practical strategies for applying state-of-the-art new treatment recommendations, based on up-to-date trial results, to everyday clinical practice.
“In the midst of this global pandemic, it’s more important than ever that we provide the best possible care to our patients with multiple cardiometabolic disorders, who are extremely vulnerable to COVID-19 as well as potential complications from their chronic disorders which many do not attend to because of the pandemic,” asserted Dr. Yehuda Handelsman, Medical Director and Principal Investigator of The Metabolic Institute of America and Chair and Program Director of the conference. “The elite global experts are coming together at the 4th HiD to lead the way for primary care and specialists to reduce mortality and cardiovascular events in these patients.”
This unique continuing medical education (CME/CE) conference, now free, aims to strengthen clinical communication and cooperation among specialists and primary care clinicians. Participants include cardiologists, endocrinologists, nephrologists, diabetologists, hepatologists, lipidologists, internists, allied health professionals, and all other interested clinicians. To adhere to the pandemic best health practices, the 4th Annual Heart in Diabetes meeting will be held as a live, interactive online virtual conference, August 21 – 24, 2020 and will be available for 90 days on demand.
Over the four-day meeting, a distinguished, internationally recognized faculty will present state-of-the-art clinical research on heart disease in diabetes to an estimated audience of 1,000 attendees. Using the latest virtual meeting technology, experts and general practitioners will discuss the implications for clinical practice, including the impact of COVID-19 on the heart and on diabetes, and the impact of the pandemic on the future health of these patients.
Sessions will cover trial outcome data and management of lipids, glucose, coronary syndromes, heart failure, renal disease, and related disorders while evaluating updated guidelines issued by the American Diabetes Association, American Heart Association, American College of Cardiology, the American Association of Clinical Endocrinologists, the European Association for the Study of Diabetes, and the European Society of Cardiology.
Interactive expert panels and debates will address key important issues. Each session will emphasize the convergence of cardiology, endocrinology, and nephrology to enhance patient care in all settings where cardiometabolic disorders are managed. The 4th HiD will also showcase new research abstracts, which will be published in the American Heart Journal.
The highlight of this year’s program is the presentation of the “Luminary in Cardiometabolic Medicine Award” to Eugene Braunwald, MD, who is a legend in Cardiology and Medicine. His keynote address, “SGLT2i and the Birth of 2 PARADIGM SHIFTS in Clinical Care” will be presented on Saturday, August 22, 2020, from 12:40-1:30 pm Eastern Time.
The 4th HID event is now FREE and will provide 28 FREE CME and MOC points. Those interested in attending the 4th Heart in Diabetes may register online at https://www.heartindiabetes.com/registration.
The meeting agenda can be seen at https://www.heartindiabetes.com/agenda.
All members of the media that are interested in attending and covering the event can register for free as well.
The Metabolic Institute of America
About Heart in Diabetes
Heart in Diabetes is a medical conference representing an educational initiative, which is a combined effort of cardiologists and endocrinologists. Since 2017, this unique forum has enabled clinicians to improve care for patients with diabetes and obesity who have cardiovascular disease and/or chronic kidney disease, often with heart failure. https://www.heartindiabetes.com/
About the Metabolic Endocrine Education Foundation (MEEF)
The Metabolic Endocrine Education Foundation (MEEF) is a leading national health foundation devoted to improving patients and public health through education. MEEF, a nonprofit organization (USA- 501 ©3), sponsors research educational activities for professional health providers, patients, and the community at large. https://www.tmioa.com/education